Cover Image

Recommendations from The Medical Education Editor

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Mark Lavercombe
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Respirology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recommendations from the Medical Education Editor
by: Mark Lavercombe
Published: (2024)

Recommendations From the Medical Education Editor
by: Mark Lavercombe
Published: (2025)

Recommendations From the Medical Education Editor
by: Mark Lavercombe
Published: (2025)

Recommendations From the Medical Education Editor
by: Mark Lavercombe
Published: (2025)

Allergic broncho‐pulmonary aspergillosis: Old disease, new frontiers
by: Eve Denton, et al.
Published: (2024)

Letter From Malaysia: Advancing Respiratory Frontiers Through Innovation, Education, and Collaboration
by: Ahmad Izuanuddin Ismail, et al.
Published: (2025)

Reducing ethnic inequities: Patterns of asthma medication use and hospital discharges in Māori in Aotearoa New Zealand
by: Allie Eathorne, et al.
Published: (2024)

Usability of a smartphone application for patients with interstitial lung disease: Results from the Registry for Better Understanding of ILD (RE‐BUILD) pilot study
by: Laura M. Glenn, et al.
Published: (2024)

CD131 antagonism blocks inflammation, emphysema and fibrosis in an asthma‐COPD overlap mouse model originating in early life
by: Hao Wang, et al.
Published: (2025)

Functional Lung Imaging Identifies Peripheral Ventilation Changes in ꞵ‐ENaC Mice
by: Nicole Reyne, et al.
Published: (2025)

Letter to the Editor: ‘Asbestosis Requiring Lung Transplantation in a Retired Hairdresser: An Occupational Exposure to Comb Through’
by: Evan Anderson, et al.
Published: (2025)

Reply to ‘Letter to the Editor: “Asbestosis Requiring Lung Transplantation in a Retired Hairdresser: An Occupational Exposure to Comb Through”’
by: Ruojin Bu, et al.
Published: (2025)

Letter from Belgium
by: Sylvia Verbanck
Published: (2024)

Letter from Japan
by: Shuhei Ideguchi, et al.
Published: (2024)

Letter from Australia
by: Christine F. McDonald
Published: (2024)

Letter from Indonesia
by: Triya Damayanti, et al.
Published: (2024)

Letter from South Africa
by: Andre Gie, et al.
Published: (2024)

Silicosis—Where to from here?
by: Hayley Barnes, et al.
Published: (2024)

Letter from Korea—Oral corticosteroid stewardship in Korea: Insights from the Korean Severe Asthma Registry (KoSAR)
by: Noeul Kang, et al.
Published: (2024)

DUETS for Light's in separating exudate from transudate
by: Astrid Gardiner, et al.
Published: (2024)

Coronary artery calcification detected on low‐dose computed tomography in high‐risk participants of an Australian lung cancer screening program: A prospective observational study
by: Asha Bonney, et al.
Published: (2024)

Leading women in respiratory clinical sciences: Letter from Australia
by: Karen Royals, et al.
Published: (2024)

Letter from the UK: Reflections on a turbulent 5 years
by: Stephen T. Holgate
Published: (2024)

Disentangling difficult‐to‐treat from severe asthma: What is the true prevalence?
by: Jennifer K. Quint
Published: (2024)

Letter from Hong Kong: Vaccination trends for respiratory viral infections in Hong Kong
by: Ken Ka Pang Chan, et al.
Published: (2024)

The challenges facing children with pulmonary tuberculosis—a catastrophe of civil war: Letter from Sudan
by: Omer Osman Babiker, et al.
Published: (2024)

Unlocking Asthma Remission: Key Insights From an Expert Roundtable Discussion
by: Dennis Thomas, et al.
Published: (2025)

Letter from Canada: Global warming and wildfire smoke pollution emerging as major threats to respiratory health
by: Allison Michaud, et al.
Published: (2024)

Current challenges with control of multi‐drug resistant TB in Peru: Lessons from the past and goals for the future
by: Roberto A. Accinelli, et al.
Published: (2024)

Letter from the Singapore Thoracic Society: Vapours, Vapes, and Vaccines—Advancing Population Lung Health in Singapore
by: Jeffrey Shuen Kai Ng, et al.
Published: (2026)

Association of short‐term exposure to PM1 with hospital admission from total and cause‐specific respiratory diseases
by: Chenghui Zhong, et al.
Published: (2024)

Increased exacerbations of bronchiectasis following recovery from mild COVID‐19 in patients with non‐cystic fibrosis bronchiectasis
by: Wang Chun Kwok, et al.
Published: (2024)

Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand
by: Hayley Barnes, et al.
Published: (2024)

Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort study
by: Masahiro Torasawa, et al.
Published: (2024)

Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti‐Fibrotic Treatment: Real‐World Data From the Dutch National Registry
by: Mark G. J. P. Platenburg, et al.
Published: (2025)

Diffusion capacity and static hyperinflation as markers of disease progression predict 3‐year mortality in COPD: Results from COSYCONET
by: Hendrik Pott, et al.
Published: (2024)

Therapeutic bronchoscopy for malignant central airway obstructions caused by non‐bronchogenic cancers: Results from the EpiGETIF registry
by: Clément Daigmorte, et al.
Published: (2024)

Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
by: John A. Mackintosh, et al.
Published: (2024)

Correction to “Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD : Evidence from NHANES 2011–2018”
Published: (2024)

Effect of off‐label targeted drugs on long‐term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry
by: Wanying Xia, et al.
Published: (2024)